According to Mohammad Hasan Asareh, "The idea of setting up a raw material production refinery in compliance with the highest international standards was formed by the private sector in 2018. "
The head of the Institute for Research and Certification of Seeds and Seedlings pointed out that: "According to estimates made, the credit needed to develop the refinery in that year was estimated at about 500 billion tomans.
However, a refinery for the production of standard materials in the field of medicinal plants has been set up in the first phase, and we hope that it will be fully operational in the coming months."
The Secretary of the Office of Development of Science and Technology of Medicinal Plants and Traditional Medicine of the Vice President also announced the formation of a scientific working group to properly guide the process of cultivation and production of modified cannabis in Iran and use its industrial and medical benefits.
He added that: "Cannabis sativa is an ancient crop native to Central Asia that, despite its importance, has been neglected by researchers for years, by re-examining and rediscovering the medicinal properties of cannabis, today this plant is among the most important medicinal plants in the world, and has a great variety and importance in industry and medicine."